Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aviron Rapid is a multi-ingredient dietary supplement developed by Neopharm Bulgaria Ltd. for the management of acute upper respiratory tract infections and flu-like symptoms. It is formulated as a combination of three naturally derived active ingredients: humic acid, a patented Spirulina protein extract known as ApoGen™, and andrographolide. The product is designed to support the body's natural immune defense function and provide antiviral effects by preventing viral attachment to host cells and inhibiting viral replication. It is typically used at the first signs of infection to reduce the duration and severity of symptoms such as high fever, chills, and muscle pain. Aviron Rapid is marketed as a food supplement and has been evaluated in randomized, placebo-controlled clinical trials to assess its efficacy in both children and adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aviron Rapid.